메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
신혜은 (충북대학교)
저널정보
한국지식재산학회 산업재산권 산업재산권 제48호
발행연도
2015.1
수록면
201 - 241 (41page)

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
This article is related to scope of protection of pharmaceutical use invention including dosage regimen According to Korean Patent Examination Guideline, medical activities such as methods for treatment of the human body by surgery, therapy or diagnosis is being regarded as industrially inapplicable inventions, therefore, cannot be patented even though they satisfy the requirements of novelty, inventive step and so on. Meanwhile, Korean supreme court usually held that new dosage regimen, correspond to a medical activity, is not a constitutional element of pharmaceutical use invention. As a result, in Korea, there was no need to discuss as to scope of protection of dosage regimen. However, recently there was a Supreme Court en banc decision ruling that in cases where the administration and dosage are added on top of the target disease or efficacy of a medicine as an invention of a product, such administration and dosage should be viewed not so much as a medical practice itself, as an expression of those features through which a medicine may fully realize its efficacy, thereby constituting an element of invention that attaches an entirely new significance to the medicine as a product. A new patent may be granted to a medicine meeting the patentability requirements, including novelty and nonobviousness, by virtue of the addition of administration and dosage. Under these circumstances, it is urgent to establish the scope of protection of pharmaceutical use invention including dosage regimen and this article suggested the reasonable protection range.

목차

등록된 정보가 없습니다.

참고문헌 (0)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0